Effects of methylazoxymethanol treatment on the GABAergic synaptosomes in the P2 fraction from developing mouse cerebellum.
Bacon
E
E
Centre de Neurochimie, Strasbourg, France.
Girard
C
C
de Barry
J
J
Gombos
G
G
D000818:Animals; D002531:Cerebellum / Q000187:drug effects* / Q000254:growth & development / Q000378:metabolism; D005445:Flunitrazepam / Q000378:metabolism; D005968:Glutamate Decarboxylase / Q000378:metabolism; D008746:Methylazoxymethanol Acetate / Q000031:analogs & derivatives* / Q000494:pharmacology; D051379:Mice; D009118:Muscimol / Q000378:metabolism; D011963:Receptors, GABA-A / Q000187:drug effects; D013574:Synaptosomes / Q000187:drug effects / Q000378:metabolism; D005680:gamma-Aminobutyric Acid / Q000378:metabolism*
D011963:Receptors, GABA-A; D009118:Muscimol; D005680:gamma-Aminobutyric Acid; D008746:Methylazoxymethanol Acetate; D005445:Flunitrazepam; D005968:Glutamate Decarboxylase; C030667:methylazoxymethanol